Nanjing Medlander Medical Technology Co.,Ltd. (SHA:688273)

Market Cap	2.86B -4.8%
Revenue (ttm)	412.52M -5.9%
Net Income	85.70M -18.5%
EPS	0.88 -18.2%
Shares Out	97.81M
PE Ratio	33.43
Forward PE	n/a
Dividend	0.80 (2.73%)
Ex-Dividend Date	May 26, 2026

Volume	1,811,083
Open	28.12
Previous Close	29.29
Day's Range	28.12 - 29.94
52-Week Range	27.18 - 61.22
Beta	0.39
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 29, 2026

About SHA:688273

Nanjing Medlander Medical Technology Co.,Ltd. engages in the research and development, manufacture, sale, and service of pelvic floor rehabilitation equipment and related products in China and internationally. It offers pelvic floor and obstetrics and gynecology rehabilitation, reproductive rehabilitation and anti-aging product, and sports rehabilitation products, as well as consumables and IT products, such as vaginal electrodes, rectal electrodes, and vaginal probes. The company also provides electronic colposcopes, biofeedback stimulation de...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2013
• Employees: 550
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 688273

Financial Performance

In 2025, SHA:688273's revenue was 431.59 million, an increase of 1.66% compared to the previous year's 424.55 million. Earnings were 102.63 million, an increase of 1.03%.

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Jul 22, 2026

Data Sources Report a data error